urvival from oesophagogastric cancer is poor, despite improvements in care. In Australia, 5-year survival is 16% and 27% for people diagnosed with oesophageal and gastric cancer, respectively. 1 Oesophagectomy and gastrectomy are potentially curative for early-stage disease. These procedures are complex and international studies have found that higher hospital volume is associated with decreased patient mortality and improved survival outcomes. [2] [3] [4] Several overseas jurisdictions have aimed to consolidate oesophagectomy and gastrectomy into specialist c e n t r e s w i t h t a r g e t s u r g i c a l caseloads. [5] [6] [7] This has the potential benefit of not only reducing unwarranted mortality seen in lower-volume centres, but also increasing the number of people offered definitive procedures 8 and improving the outcomes of existing higher-volume centres at which surgical volume is further increased. 9 To help inform health policy decision making, we examined the relationship between hospital volume and population-level short-term morbidity and mortality and longer-term survival outcomes for patients who underwent oesophagectomy or gastrectomy for oesophagogastric cancer in New South Wales between 2001 and 2008 using linked cancer notification and hospital admissions data.
Methods
We conducted a retrospective, population-based cohort study using linked de-identified data from the NSW Central Cancer Registry (CCR) and NSW Admitted Patient Data Collection (APDC). The CCR records mandatory notifications of cancer cases diagnosed in NSW residents and is linked to the National Death Index. The APDC records all public and private hospital admissions in NSW. The Centre for Health Record Linkage linked the data using probabilistic, privacy-preserving methods with ethics approval from the NSW Population and Health Services Research Ethics Committee (HREC/ 09/CIPHS/23).
Study population
The study included At the time of data collation, dates of death on the CCR were complete for cancer deaths up to 31 December 
Statistical analyses
Multilevel logistic regression models were estimated for binary outcomes and multilevel Cox proportional hazards models were estimated for survival outcomes. Age, Charlson comorbidity score, extent of cancer spread, urgency of admission, hospital type and year of procedure (known confounders) were included in all models regardless of statistical significance. Sex and, for oesophagectomy, tumour histology were included in all survival models. Other variables were included if the P value for univariate significance was less than 0.25, with backwards elimination based on P values and reduction in Akaike information criterion. A sensitivity analysis was performed, including hospital volume as a continuous variable and excluding hospitals that performed fewer than eight relevant procedures during the study period because small group size with a low-prevalence outcome can inflate error in multilevel logistic regression models. 13 Analyses were performed using Stata/MP 12 (StataCorp) and SAS 9.3 (SAS Institute).
Results

From
From 2001 to 2008, 908 oesophagectomies were performed in a total of 42 NSW hospitals, of which 48.6% (441) were in higher-volume hospitals, and 1621 gastrectomies were performed in a total of 84 NSW hospitals, of which 54.5% (884) were in higher-volume hospitals (Box 1). Gastrectomy patients in higher-volume hospitals were younger (< 65 
Surgical outcomes
Length of stay was similar in both hospital volume groups: one-third and one-quarter of people stayed in hospital longer than 21 days for oesophagectomy and gastrectomy, respectively (Appendix 4). Overall, about 12% of people had an unplanned readmission within 28 days of discharge for both procedures.
Overall 30-day and 90-day mortality was 4.1% (37/905) and 7.5% (67/ 891) for oesophagectomy and 4.4% (70/1609) and 9.1% (143/1577) for gastrectomy, respectively. Lower hospital volume was not associated with higher 90-day mortality after oesophagectomy -the unadjusted odds ratio (OR) was 1.27 (95% CI, 0.77-2.09; P = 0.36), and the adjusted OR was 1.42 (95% CI, 0.84-2.39; P = 0.19) (Box 2). In the sensitivity analysis, including hospital volume as a continuous variable and excluding small sample size hospitals, the effect of an increase in one oesophagectomy per year was a 7% decrease in 90-day mortality after oesophagectomy (OR, 0.93 [95% CI, 0.86-1.00]; P = 0.06). Thirty-day mortality after gastrectomy was 5.1% (37/732) in lower-volume hospitals and 3.8% (33/877) in highervolume hospitals (adjusted OR, 1.37 [95% CI, 0.80-2.33]; P = 0.25).
Oesophagectomy in a lower-volume hospital was associated with significantly lower 5-year absolute survival compared with oesophagectomy in a higher-volume hospital (adjusted hazard ratio [HR] for lowervolume hospitals, 1.28 [95% CI, 1.10-1.49]; P = 0.002) (Box 3, Box 4). The association was almost the same for conditional 5-year survival, in which the effect of perioperative deaths on survival is removed. Overall, there was a non-significant trend for gastrectomy in a higher-volume hospital to be associated with higher 5-year absolute survival compared with gastrectomy in a lower-volume hospital (adjusted HR for lower-volume hospitals, 1.11 [95% CI, 0.95-1.31]; P = 0.19) (Box 3, Box 4). When survival of people who had localised cancer within 4 months of diagnosis was examined for gastrectomy, absolute 5-year survival was significantly lower for those who had surgery in a lowervolume hospital compared with those who had surgery in a higher-volume hospital (adjusted HR for lower-volume hospitals, 1.83 [95% CI, 1.28-2.61]; P = 0.001) (Box 3). The exclusion of patients diagnosed in 2007, for whom follow-up data may not have been complete, did not substantially change the estimated HRs for the survival analyses.
Discussion
We found evidence of a relationship between hospital volume and patient outcomes for people who underwent oesophagectomy for oesophagogast- * HRs were calculated using Cox proportional hazards models, and an HR > 1 indicates a higher hazard (ie, poorer survival); lower-volume and higher-volume hospitals performed р 6 and > 6 procedures per year, respectively. † Analysis of conditional survival includes patients who survived > 30 days after surgery. ◆ ric cancer in NSW. There was no clear evidence of such a relationship for people who underwent gastrectomy overall, but resection in a higher-volume hospital was associated with significantly improved 5-year survival for people with localised gastric cancer who underwent gastrectomy. These results are consistent with those of international studies, in which the relationship for gastrectomy is weaker t h a n f o r t h e m o r e c o m p l e x oesophagectomy. 4, 14 Rates of surgical resection for oesophagogastric cancer are decreasing and hospital volumes did not increase during our study period. The median annual number of procedures performed was four or fewer across the 22-30 and 45-55 hospitals performing oesophagectomy and gastrectomy, respectively, each year.
Although our study was population based and covered an 8-year period, it had a small sample size compared with many international studies. 4 Sample size, prevalence of the outcome and effect size affect statistical power, and these factors may have limited our ability to detect significant differences, particularly for mortality outcomes. Risk adjustment is important because case complexity and patient characteristics may influence the choice of hospital to which patients are referred. In our study, risk adjustment included measures of tumour extent and comorbidity, as well as sex, age, socioeconomic status, tumour site and histology, urgency of admission and hospital type. Risk adjustment of oesophagectomy mortality outcomes increased the size and decreased the P value of the hospital volume effect, similar to other studies. 2 Higher-volume hospitals performed gastrectomy on a larger proportion of patients with distant cancer spread. Clinical cancer stage and measures of comorbidity such as performance status may improve risk adjustment. Incomplete risk adjustment may have left residual confounding and restricted our ability to detect significant differences.
Outcomes for oesophagogastric cancer surgery in NSW are good, despite hospital volumes being low by international standards. Thirty-day mortality of 4.1% and 4.4% for oesophagectomy and gastrectomy, respectively, and 5-year survival of about 40% for both procedures compares well to results from other countries. [14] [15] [16] [17] [18] [19] Invasive surgery for advanced gastric cancer may be necessary at times, but information on surgical intent (curative or palliative) was not available from our data sources. We therefore included both curative-intent and palliative-intent resections in our study, which affects comparisons of our results with those of studies of curative-intent resections only.
There are no high-volume hospitals in NSW by international standards. For gastrectomy in Europe, one study has shown that lower 30-day mortality is only seen once hospitals perform more than 20 gastrectomies per year for gastric cancer.
14 No hospital in NSW reached this volume during the study period, limiting our ability to assess a volume-outcome relationship. Japan has some of the best oesophagectomy mortality outcomes in the world, with an overall 30-day mortality of 1.2% (390/31 380). 20 Nevertheless, a volume-outcome relationship is present: high-volume hospitals (40 or more oesophagectomies per year) achieve significantly lower mortality than hospitals that perform fewer than five per year (0.6% v 2.0%). So there is potential to significantly improve outcomes for patients in NSW.
The association between hospital volume and outcome may be partly due to high-volume surgeons working in high-volume hospitals and partly due to hospital factors. 21, 22 In our study, no data on surgeon volume were available. In general, hospital volume has been found to be more predictive of outcomes than surgeon volume, 2 although this is not universal. 21 Hospital characteristics associated with improved outcomes in higher-volume hospitals are likely to be multifactorial. Preoperative and postoperative care for oesophagogastric resection for cancer is complex; it involves extensive staging, intensive care, interventional radiology, (neo) adjuvant therapy, specialised nursing and allied health care. A high caseload supports the development of specialist multidisciplinary services and care teams.
Maintaining equitable access to multidisciplinary care is important for the 1000 people diagnosed with oesophagogastric cancer in NSW each year. In Ontario, Canada, a requirement for hospitals to perform 20 oesophagectomies per year has been established; in areas that cannot support this volume, a hospital target of seven is set, with a requirement to establish links with a major centre. The effect of hospital volume on longer-term survival after oesophagectomy in Ontario has not yet been reported. 23 In the Netherlands, consolidation of surgery has been associated with improvements in survival of surgical and non-surgical cardio-oesophageal cancer patients. 24 The arguments for greater consolidation are compelling. In NSW, achieving this and improving outcomes for people with oesophagogastric cancer will require ongoing consultation with clinicians, hospital administrators and governments.
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